These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1483951)

  • 1. Detection of locally recurrent colorectal cancer with radiolabeled monoclonal antibody H-15.
    Sakamoto J; Kato T; Watanabe T; Murayama H; Wada K; Sato T; Takagi H; Kondo K; Sasaki F; Kido C
    Jpn J Cancer Res; 1992 Dec; 83(12):1373-81. PubMed ID: 1483951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of recurrent intestinal carcinoma with indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody CEA102.
    Nakada K; Sakamoto J; Watanabe T; Itoh K; Akiyama S; Takagi H
    Jpn J Cancer Res; 1997 Jun; 88(6):605-13. PubMed ID: 9263539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33.
    Welt S; Divgi CR; Real FX; Yeh SD; Garin-Chesa P; Finstad CL; Sakamoto J; Cohen A; Sigurdson ER; Kemeny N
    J Clin Oncol; 1990 Nov; 8(11):1894-906. PubMed ID: 2230877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
    Welt S; Divgi CR; Scott AM; Garin-Chesa P; Finn RD; Graham M; Carswell EA; Cohen A; Larson SM; Old LJ
    J Clin Oncol; 1994 Jun; 12(6):1193-203. PubMed ID: 8201382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic analysis of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA102 in colorectal cancer using computed radiography.
    Satoh T; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Itoh K; Sakuma S; Takagi H
    Jpn J Cancer Res; 1992 Apr; 83(4):379-86. PubMed ID: 1506272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoscintigraphy of colorectal cancer using 111In-labeled monoclonal antibody to mucin.
    Sakahara H; Onodera H; Shirato M; Yao Z; Ohshio G; Kobayashi H; Hosono M; Yano S; Nakada H; Imamura M
    Cancer Immunol Immunother; 1995 Sep; 41(3):157-61. PubMed ID: 7553684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms.
    Goldenberg DM; Kim EE; Bennett SJ; Nelson MO; Deland FH
    Gastroenterology; 1983 Mar; 84(3):524-32. PubMed ID: 6295871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.
    Welt S; Divgi CR; Kemeny N; Finn RD; Scott AM; Graham M; Germain JS; Richards EC; Larson SM; Oettgen HF
    J Clin Oncol; 1994 Aug; 12(8):1561-71. PubMed ID: 8040668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
    de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
    Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT.
    Stomper PC; D'Souza DJ; Bakshi SP; Rodriguez-Bigas M; Burke PA; Petrelli NJ
    Radiology; 1995 Dec; 197(3):688-92. PubMed ID: 7480740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors.
    Sickle-Santanello BJ; O'Dwyer PJ; Mojzisik C; Tuttle SE; Hinkle GH; Rousseau M; Schlom J; Colcher D; Thurston MO; Nieroda C
    Dis Colon Rectum; 1987 Oct; 30(10):761-4. PubMed ID: 3652889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.
    Oosterwijk E; Bander NH; Divgi CR; Welt S; Wakka JC; Finn RD; Carswell EA; Larson SM; Warnaar SO; Fleuren GJ
    J Clin Oncol; 1993 Apr; 11(4):738-50. PubMed ID: 8478666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patients.
    Roselli M; Guadagni F; Buonomo O; Belardi A; Vittorini V; Cavazzana A; Spagnoli LG; Cipriani C; Casciani CU
    Anticancer Res; 1996; 16(2):883-9. PubMed ID: 8687145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
    Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
    J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.
    Yao YF; Yang Z; Li ZF; Gu J
    World J Gastroenterol; 2007 Mar; 13(12):1841-6. PubMed ID: 17465478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma.
    Mach JP; Chatal JF; Lumbroso JD; Buchegger F; Forni M; Ritschard J; Berche C; Douillard JY; Carrel S; Herlyn M
    Cancer Res; 1983 Nov; 43(11):5593-600. PubMed ID: 6616486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo comparison of binding of 99m-Tc-labeled anti-CEA MAb F33-104 with 99m-Tc-labeled anti-CEA MAb BW431/26.
    Watanabe N; Oriuchi N; Sugiyama S; Kuroki M; Matsuoka Y; Tanada S; Murata H; Inoue T; Sasaki Y
    Nuklearmedizin; 1999; 38(4):115-9. PubMed ID: 10392376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Typical findings and erroneous findings in SPECT-radioimmunoscintigraphy using 99mTc-labeled CEA antibodies in colorectal tumors].
    Barzen G; Felix R
    Aktuelle Radiol; 1992 Jul; 2(4):212-9. PubMed ID: 1504120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.